Zdrowie i gospodarka · 02/03/2012
FDA Announces Public Hearing on Biosimilar Product Guidances and Requests Comments
The FDA is hosting a public hearing to gather input on draft guidances for biosimilar products, which are part of the implementation of the Biologics Price Competition and Innovation Act of 2009, and is also seeking public input on future policies regarding biosimilars.